Literature DB >> 32452355

COVID-19: the new challenge for rheumatologists. First update.

Francesco Ferro1, Elena Elefante1, Ilaria Puxeddu2, Chiara Baldini1, Elena Bartoloni3, Claudia Baratè4, Sara Galimberti4, Rosaria Talarico1, Marta Mosca1, Stefano Bombardieri5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32452355

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN： 0392-856X            Impact factor:   4.473


× No keyword cloud information.
  11 in total

Review 1.  Autoinflammatory and autoimmune conditions at the crossroad of COVID-19.

Authors:  Yhojan Rodríguez; Lucia Novelli; Manuel Rojas; Maria De Santis; Yeny Acosta-Ampudia; Diana M Monsalve; Carolina Ramírez-Santana; Antonio Costanzo; William M Ridgway; Aftab A Ansari; M Eric Gershwin; Carlo Selmi; Juan-Manuel Anaya
Journal:  J Autoimmun       Date:  2020-06-16       Impact factor: 7.094

Review 2.  Deciphering SARS-CoV-2 Virologic and Immunologic Features.

Authors:  Grégorie Lebeau; Damien Vagner; Étienne Frumence; Franck Ah-Pine; Xavier Guillot; Estelle Nobécourt; Loïc Raffray; Philippe Gasque
Journal:  Int J Mol Sci       Date:  2020-08-18       Impact factor: 5.923

3.  The clinical course of COVID-19 in systemic sclerosis patients, report from 150 patients.

Authors:  Zahra Tamartash; Ali Javinani; Farhad Gharibdoost; Reza Atef Yekta; Amirmohammad Mohammadzadegan; Hoda Kavosi
Journal:  Intern Emerg Med       Date:  2021-04-16       Impact factor: 3.397

4.  Therapeutic approaches to pediatric COVID-19: an online survey of pediatric rheumatologists.

Authors:  Ales Janda; Catharina Schuetz; Scott Canna; Mark Gorelik; Maximilian Heeg; Kirsten Minden; Claas Hinze; Ansgar Schulz; Klaus-Michael Debatin; Christian M Hedrich; Fabian Speth
Journal:  Rheumatol Int       Date:  2021-03-08       Impact factor: 2.631

5.  Does immunosuppressive treatment entail an additional risk for children with rheumatic diseases? A survey-based study in the era of COVID-19.

Authors:  Oya Koker; Fatma Gul Demirkan; Gulsah Kayaalp; Figen Cakmak; Ayse Tanatar; Serife Gul Karadag; Hafize Emine Sonmez; Rukiye Omeroglu; Nuray Aktay Ayaz
Journal:  Rheumatol Int       Date:  2020-08-02       Impact factor: 2.631

6.  Symmetric peripheral polyarthritis developed during SARS-CoV-2 infection.

Authors:  Rosaria Talarico; Chiara Stagnaro; Francesco Ferro; Linda Carli; Marta Mosca
Journal:  Lancet Rheumatol       Date:  2020-07-13

7.  TEN/SJS-like lupus erythematosus presentation complicated by COVID-19.

Authors:  Mohammad Shahidi-Dadras; Farnaz Araghi; Arman Ahmadzadeh; Azadeh Rakhshan; Mohammadreza Tabary; Sahar Dadkhahfar
Journal:  Dermatol Ther       Date:  2020-12-10       Impact factor: 3.858

8.  Prevalence of coronavirus disease 2019 in rheumatic patients and evaluation of the effect of disease-modifying anti-rheumatic drugs.

Authors:  Soroush Moradi; Maryam Masoumi; Somayeh Mohammadi; Jamshid Vafaeimanesh; Mohaddeseh Mohseni; Hossein Mahdavi; Armin Aryannejad
Journal:  Intern Emerg Med       Date:  2020-10-31       Impact factor: 3.397

9.  Rheumatology university faculty opinion on coronavirus disease-19 (COVID-19) vaccines: the vaXurvey study from Egypt.

Authors:  Nevin Hammam; Samar Tharwat; Rawhya R El Shereef; Ahmed M Elsaman; Noha M Khalil; Hanan M Fathi; Mohamed N Salem; Hanan M El-Saadany; Nermeen Samy; Amany S El-Bahnasawy; Yousra H Abdel-Fattah; Marwa A Amer; Emad ElShebini; Amira T El-Shanawany; Dina H El-Hammady; Rasha Abdel Noor; Marwa ElKhalifa; Faten Ismail; Rasha M Fawzy; Amany R El-Najjar; Zahraa I Selim; Nouran M Abaza; Ahmed R Radwan; Mervat IAbd Elazeem; Wael Abdel Mohsen; Abdel Hafeez Moshrif; Eman F Mohamed; Loay I Aglan; Soha Senara; Maha E Ibrahim; Iman Khalifa; Rasha El Owaidy; Noha El Fakharany; Reem Hamdy A Mohammed; Tamer A Gheita
Journal:  Rheumatol Int       Date:  2021-07-09       Impact factor: 2.631

10.  Efficacy of human coronavirus immune convalescent plasma for the treatment of corona virus disease -19 disease in hospitalized children: A protocol for systematic review and meta analysis.

Authors:  Hua Bai; Yongjia Ji; Jia Wang; Xuehong Zhang
Journal:  Medicine (Baltimore)       Date:  2020-11-06       Impact factor: 1.817
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.